Medicines in clinical development
Global · 2025
Medicines in clinical development worldwide stood at 12,900 in 2025 (IFPMA).
- Publisher
- IFPMA
- Authority tier
- T2 National
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Other sources disagree
1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.
| Value | Divergence | Source organisation | Document | Locator | Details |
|---|---|---|---|---|---|
| 8,000 | -38.0% | PhRMA | Research & Development | Policy Framework | Open record |
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0
- MLA
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0.
- Chicago
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0.
- BibTeX
- @misc{ifpma2025medicinesbjmgf0, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary Source
- Publisher
- IFPMA · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Type
- Press release
- Published
- —
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Archival URI
- /stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF0